1. |
Plant sterols/sterolins: anti-inflammatory effects |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
2. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
3. |
Leukotriene antagonists increase hospitalisation risk in asthma |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
4. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
5. |
Duloxetine effective in stress incontinence |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
6. |
Enfuvirtide: a new revolu-T20n in HIV treatment? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 7-9
Raewyn Poole,
Preview
|
|
摘要:
The first of the fusion inhibitors, enfuvirtide [T-20, 'Fuzeon'] has been shown to enhance the efficacy of an optimised base regimen in heavily pretreated patients with HIV infections. Eagerly anticipated 24-week results from the TORO*1 and TORO 2 studies were presented at the XIV International AIDS Conference [Barcelona, Spain; July 2002]. Patients treated with enfuvirtide were significantly more likely than those receiving the background regimen alone to achieve viral RNA levels of ≤ 400 copies/ml, and had a longer time to virological failure. Enfuvirtide was generally well tolerated, and did not appear to increase the incidences of adverse events, compared with the optimised regimen alone; although injection site reactions were common in enfuvirtide recipients, only a small proportion discontinued treatment as a result.'These pivotal studies of T-20 were conducted among heavily treatment-experienced HIV patients, a population for whom treatment options are limited',commented Dr Jay Lalezari from Quest Clinical Research in San Francisco, US.'It is exciting and encouraging to see that when T-20 is added to the best available combination of conventional antiretrovirals, patients are twice as likely to achieve undetectable levels of the virus than those who took combination therapy without T-20, bringing new hope to these patients'.
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
7. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
8. |
Antipsychotics + mood stabilisers in bipolar disorders |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
9. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
10. |
News from the 8th International Conference on Alzheimer's Disease and Related Disorders |
|
Inpharma Weekly,
Volume &NA;,
Issue 1353,
2002,
Page 12-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|